SBFM — Sunshine Biopharma Share News
0.000.00%
Last trade - 00:00- $2.28m
- -$11.45m
- $36.31m
Sunshine Biopharma Inc expected to post a loss of 11 cents a share - Earnings Preview
Sunshine Biopharma Inc expected to post earnings of 11 cents a share - Earnings Preview
Sunshine Biopharma Inc expected to post earnings of 11 cents a share - Earnings Preview
Brief: Sunshine Biopharma Inc Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Sunshine Biopharma - On Sept 9 Got Letter From Nasdaq That Co Regained Compliance With Bid Price Requirement
Sunshine Biopharma Inc reports results for the quarter ended in June - Earnings Summary
Sunshine Biopharma Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: Sunshine BiopharmaGot Nasdaq Letter That Based On Review Of Co's Public Filings,Supporting Materials Submitted, Determined To Delist Co's Securities
Sunshine Biopharma Inc reports results for the quarter ended in March - Earnings Summary
Sunshine Biopharma Inc expected to post a loss of $8.00 a share - Earnings Preview
Brief: Sunshine Biopharma Says Filed Certificate Of Amendment To Effect 1-For-100 Reverse Stock Split
Brief: Altium Capital Management Reports 9.99% Passive Stake In Sunshine Biopharma - SEC Filing
Sunshine Biopharma Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Sunshine Biopharma Inc Files For Offering Of Up To 17.9 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Sunshine Biopharma Announces Pricing Of $5 Mln Private Placement
Sunshine Biopharma jumps on Q1 sales boost from generic unit Nora Pharma
Brief: Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results And Provides Corporate Update
Brief: Sunshine Biopharma Inc-On March 24, Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Brief: Sunshine Biopharma Signs Exclusive Worldwide License For PLpro-Based COVID-19 Treatment